| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6821336 | Schizophrenia Research | 2018 | 7 Pages |
Abstract
We identified an association between the concurrent use of sodium valproate and an increased risk of clozapine associated neutropenia. These results, taken in combination with the results from previous case series, suggest that the risk of clozapine associated neutropenia could be reduced by avoiding concurrent valproate treatment.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Steffi Malik, John Lally, Olesya Ajnakina, Megan Pritchard, Amir Krivoy, Fiona Gaughran, Hitesh Shetty, Robert J. Flanagan, James H. MacCabe,